Next Article in Journal
The Generation of Dual-Targeting Fusion Protein PD-L1/CD47 for the Inhibition of Triple-Negative Breast Cancer
Next Article in Special Issue
Tumor Temperature: Friend or Foe of Virus-Based Cancer Immunotherapy
Previous Article in Journal
Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias
Previous Article in Special Issue
Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59
 
 
Review

Article Versions Notes

Biomedicines 2022, 10(8), 1842; https://doi.org/10.3390/biomedicines10081842
Action Date Notes Link
article xml file uploaded 30 July 2022 12:41 CEST Original file -
article xml uploaded. 30 July 2022 12:41 CEST Update https://www.mdpi.com/2227-9059/10/8/1842/xml
article pdf uploaded. 30 July 2022 12:41 CEST Version of Record https://www.mdpi.com/2227-9059/10/8/1842/pdf
article html file updated 30 July 2022 12:42 CEST Original file -
article html file updated 13 August 2022 04:47 CEST Update https://www.mdpi.com/2227-9059/10/8/1842/html
Back to TopTop